Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: A prospective observational cohort study of 373 patients

Clinical Infectious Diseases

Volumn 48, Issue 1, 2009, Pages 65-71

  Buchholtz, Kristine ^a   Larsen, Carsten T ^a   Hassager, Christian ^b   Bruun, Niels E ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GENTAMICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG BLOOD LEVEL; ENTEROCOCCUS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MORTALITY; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREATMENT DURATION; UNITED STATES; UNIVERSITY HOSPITAL;

AGED; COHORT STUDIES; CREATININE; DENMARK; ENDOCARDITIS; ENTEROCOCCUS; FEMALE; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, ACUTE; STAPHYLOCOCCUS AUREUS; STATISTICS AS TOPIC; STREPTOCOCCUS; TIME FACTORS;

EID: 57749089858     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/594122     Document Type: Article

References (28)

1. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54:971-81.
2. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25:267-76.
3. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394-434.
4. English WP, Williams MD. Should aminoglycoside antibiotics be abandoned? Am J Surg 2000; 180:512-5.
5. Gavalda J, Onrubia PL, Gomez MT, et al. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother 2003; 52:514-7.
6. Freundlich M, Thomsen RW, Pedersen L, West H, Schonheyder HC. Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study. J Antimicrob Chemother 2007; 60:1115-23.
7. Naqvi TZ, Boyatt J, Siegel RJ. Predictors of mortality in paravalvular abscess. J Am Soc Echocardiogr 2005; 18:1404-8.
8. Thuny F, Disalvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112:69-75.
9. Buchholtz K, Larsen CT, Hassager C, Bruun NE. Infective endocarditis: mortality can be predicted by kidney function at time of admission. J Am Coll Cardiol 2007; 49:305A.
10. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998; 49:96-101.
11. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
12. Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen JM. Rapid evaluation of creatinine clearance. Acta Med Scand 1974; 196:517-20.
13. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet 1971; 1:1133-4.
14. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98:1949-84.
15. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2006;CD003344.
16. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65.
17. Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113: 2713-23.
18. De Santo NG, Cirillo M, Perna A, et al. The kidney in heart failure. Semin Nephrol 2005; 25:404-7.
19. Khan NA, Ma I, Thompson CR, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 2006; 17:244-53.
20. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2006.
21. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113:1063-70.
22. Dickerman SA, Abrutyn E, Barsic B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007; 154:1086-94.
23. Sexton DJ, Spelman D. Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Infect Dis Clin North Am 2002; 16:507-21
24. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart 2002; 88:61-6.
25. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of inhospital death in infective endocarditis. Circulation 2004; 109:1745-9.
26. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003; 289:1933-40.
27. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354-61.
28. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345:1318-30.